Stemina Launches Autism Clinical Study
Stemina Biomarker Discovery Inc. today announced the launch of the largest clinical study of the metabolism of children with autism spectrum disorder (ASD) ever conducted. The Children’s Autism Metabolome Project or “CAMP” study will enroll 1,500 subjects from six sites across the country. CAMP will attempt to confirm that sets of metabolic biomarkers can detect subtypes of ASD.
- A fasting blood draw is required for the NPDX ASD test. Make sure your child has had nothing to eat or drink except… https://t.co/0fjgcL0yUO22 hours ago
- Open peer review, as shown on sites like Publons, has advantages that could improve the research and review process… https://t.co/ksiq0rB6KCyesterday
- RT @AutismParentMag: How Music Can Help Those With ASD Cope With Anxiety https://t.co/TVdCD8HPHw #Autism https://t.co/uTXxoT2owt2 days ago